Cargando…
Platelet Gene Therapy Promotes Targeted Peripheral Tolerance by Clonal Deletion and Induction of Antigen-Specific Regulatory T Cells
Delivery of gene therapy as well as of biologic therapeutics is often hampered by the immune response of the subject receiving the therapy. We have reported that effective gene therapy for hemophilia utilizing platelets as a delivery vehicle engenders profound tolerance to the therapeutic product. I...
Autores principales: | Luo, Xiaofeng, Chen, Juan, Schroeder, Jocelyn A., Allen, Kenneth P., Baumgartner, Christina K., Malarkannan, Subramaniam, Hu, Jianda, Williams, Calvin B., Shi, Qizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136275/ https://www.ncbi.nlm.nih.gov/pubmed/30237796 http://dx.doi.org/10.3389/fimmu.2018.01950 |
Ejemplares similares
-
Platelet gene therapy induces robust immune tolerance even in a primed model via peripheral clonal deletion of antigen-specific T cells
por: Li, Jing, et al.
Publicado: (2021) -
Transplant Tolerance, Not Only Clonal Deletion
por: Hall, Bruce M., et al.
Publicado: (2022) -
Failure of clonal deletion in neonatally thymectomized mice: tolerance is preserved through clonal anergy
Publicado: (1990) -
Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis
por: Cai, Yuanhua, et al.
Publicado: (2022) -
B7/CD28 in Central Tolerance: Costimulation Promotes Maturation of Regulatory T Cell Precursors and Prevents Their Clonal Deletion
por: Hinterberger, Maria, et al.
Publicado: (2011)